COO/CFO · Gossamer Bio, Inc. · Gossamer Bio, Inc. — Pre-Funded Warrant (Right to Buy)
Side
A
Value
$25K
Shares
25
Price
$1,000
Executed
Aug 24, 2026
Disclosed
Aug 26, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Aug 24 executedAug 26, 2026 disclosed
GOSS · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
$25K reported value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Gossamer Bio, Inc. — Pre-Funded Warrant (Right to Buy)
Ticker
GOSS
Shares
25
Price per share
$1,000
Value
$25,000
Execution date (reported)
Aug 24, 2026
Owned after transaction
25 shares
Days from execution to publication
2
Calculation
Value = shares × reported price per share
Shares: 25
Price: $999.999
= $25,000
What this establishes
Giraudo Bryan filed this Form 4 reporting a grant or award of GOSS on Aug 24, 2026. It became public on Aug 26, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
COO/CFO
Giraudo Bryancik:0001740847
Issuer
Gossamer Bio, Inc.cik:0001728117
Revision history · 0
No field has changed since this record was first ingested.
